NEOGEN CORP (NEOG)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NEOG
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NEOG | Director; Chief Executive Officer | 60 | ["Logistics", "Global Sourcing", "Operations", "Executive Leadership", "Mergers & Acquisitions", "Sales & Marketing", "Regulatory", "International"] | ["Compensation", "Governance"] | 2025 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BRKR | Chief Executive Officer | 61 | ["Chief Executive Officer of QIAGEN since March 2020","Member of QIAGEN's Managing Board since 2021","Held roles of increasing responsibility during 15 years with bioMérieux SA","Corporate Vice President, Global Commercial Operations, Investor Relations in the Greater China Region","Senior management roles in several leading international companies","Earned degrees and certifications from Sciences Po Paris, the London School of Economics, the College of Europe, Harvard Business School, and Centro de Comercio Exterior de Barcelona","Appointed Conseiller du Commerce Extérieur by the French government"] | ["AdvaMedDx Board of Directors"] | 2026 |
Biography sourced from the proxy statement filing.
Thierry Bernard is Chief Executive Officer of QIAGEN N.V., a leading global provider of sample-to-insight solutions that are used to transform biological materials into molecular insights. Mr. Bernard was named to the role in March 2020 after joining QIAGEN in 2015. Prior to his role at QIAGEN, Mr. Bernard spent 15 years with bioMérieux SA, where he held roles of increasing responsibility, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations and the Greater China Region. He also held senior management roles in other leading international companies.